多瑞医药 (301075)
Tibet Duo Rui Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameTibet Duorui Pharmaceutical Co., Ltd.
Listing Date2021-09-29
Issue Price27.27RMB
Registered Capital800010k RMB
Legal RepresentativeDeng Yong
Registered AddressNo. 9, Chuangye Avenue, Zone A, Economic and Technological Development Zone, Qamdo City, Tibet Autonomous Region
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of chemical drug preparations and their active pharmaceutical ingredients.
Company ProfileTibet Duorui Pharmaceutical Co., Ltd. is a high-quality enterprise introduced from mainland China to Qamdo City, Tibet Autonomous Region. Through relentless efforts and integration of premium resources, the company now owns Hubei Benyang Pharmaceutical Co., Ltd., Hubei Duorui Pharmaceutical Co., Ltd., Wuhan Jianuokang Pharmaceutical Technology Co., Ltd., Hubei Jiaruimei Pharmaceutical Technology Co., Ltd., Gong'an County Renkang Pharmaceutical Technology Co., Ltd., Tibet Chenyun Industrial Co., Ltd., and Tibet Shengyun Industrial Co., Ltd. It has evolved into a comprehensive pharmaceutical group integrating pharmaceutical R&D, production, sales, and pharmaceutical industry investment.
Guided by the goal of meeting modern clinical needs, the company focuses on high-end generic drugs and improved innovative drugs in specialized segments such as plasma substitutes, emergency rescue medications, pediatric drugs, and psychiatric medications. It continuously enriches its product pipeline, adheres to a combination of imitation and innovation, and takes the R&D, production, and sales of chemical drug preparations and their APIs as its main business. The company develops steadily and actively enhances its R&D innovation capabilities.
Stock Details
1. Key Indicators
- Total Shares(W): 8000.00
- Circulating A-Shares(W): 8000.00
- Earnings Per Share(RMB): -1.0064
- Net Assets Per Share(RMB): 7.4613
- Operating Revenue(W RMB): 13699.80
- Total Profit(W RMB): -11115.16
- Net Profit Attributable to Parent(W RMB): -7972.77
- Net Profit Growth Rate(%): -366.82
- Weighted Return on Equity(%): -12.9500
- Operating Cash Flow Per Share(RMB): -0.4340
- Undistributed Profit Per Share(RMB): 0.1207
- Capital Reserve Per Share(RMB): 6.3356
2. Main Business
The main business covers:
- Research, development, production, and sales of chemical drug preparations and intermediates.
- Research, development, production, and sales of active pharmaceutical ingredients (APIs).
3. Company Basic Information
- Company Name: Tibet Duo Rui Pharmaceutical Co., Ltd.
- Listing Date: 2021-09-29
- Industry: Pharmaceutical Manufacturing
- Address: 3rd Floor, Building 1, Biomedical Park, Zone A, Economic Development Zone, Changdu City, Tibet Autonomous Region
- Website: www.duoruiyy.com
- Company Profile：The company's predecessor was Hubei Duorui Pharmaceutical Co., Ltd., which was restructured into a joint-stock company in February 2020. Based on its audited net assets as of December 31, 2019, the company converted its equity into share capital and was listed on the Shenzhen Stock Exchange ChiNext Board in September 2021. The company is primarily engaged in the research, development, production, and sales of chemical drug preparations, intermediates, and APIs.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tibet Jiakang Times Technology Development Co., Ltd. | General Legal Person | 4667.80 | 58.35 |
| 2 | Qingdao Qingchang Enterprise Management Partnership (Limited Partnership) | General Legal Person | 589.83 | 7.37 |
| 3 | Jiaxing Qiuyang Equity Investment Partnership (Limited Partnership)-Jiaxing Qiuyu Investment Partnership (Limited Partnership) | General Legal Person | 68.68 | 0.86 |
| 4 | Shenzhen Qianhai Houbo Capital Management Co., Ltd. - Houbo Lingwang No.2 New Opportunity Private Securities Investment Fund | Private Securities Investment Fund | 31.48 | 0.39 |
| 5 | Huatai Securities Co., Ltd. | Securities Firm | 24.68 | 0.31 |
| 6 | Shenzhen Qianhai Houbo Capital Management Co., Ltd. - Houbo Shengshi Family Opportunity Private Securities Investment Fund | Private Securities Investment Fund | 23.90 | 0.30 |
5. Concept Sectors
- Infant & Child Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Loss-Making Stocks
- Consecutive Losses
- Tender Offer
- Intended Share Reduction
- Control Change
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information